Physician profile
Steven Behram
NPI 1184687196
$18,483.41
in general payments reported to CMS, 2019-2025
43 companies · $350 in 2025
The $350 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $1,419 · 2021: $945 · 2022: $793 · 2023: $535 · 2024: $228 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,113.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,113.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Covidien Lp | $15,109.00 | 2019-2020 | |
| Abbvie INC. | $491.08 | 2019-2023 | Orilissa, Lo Loestrin Fe, Liletta |
| Aspira Women'S Health INC | $448.99 | 2021-2023 | Ova1 |
| Therapeuticsmd, INC. | $293.71 | 2019-2022 | |
| Astellas Pharma US INC | $242.65 | 2023-2025 | Veozah |
| Hologic Sales and Service, LLC | $211.55 | 2020-2025 | Aptima, Novasure, Myosure Tissue Removal Device |
| Coopersurgical, INC. | $127.65 | 2019-2025 | Paragard T 380a, Summit Doppler, Mara Console |
| Renovia INC | $119.55 | 2021 | |
| Novo Nordisk INC | $109.02 | 2023-2025 | Wegovy, Saxenda |
| Myriad Women'S Health, INC. | $90.75 | 2023 | |
| Lilly USA, LLC | $86.21 | 2025 | Zepbound |
| Pfizer INC. | $84.86 | 2022-2024 | |
| Sumitomo Pharma America, INC. | $73.85 | 2023-2024 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $72.41 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $71.04 | 2019-2022 |
Show all 42 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Behram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.